ThE_uNKNowN@Johnson__MD

MD 🩺 | Research fellow | The views expressed here are my own and do not reflect the views of the institutions with which I am affiliated

instagram.com/deejay_sax?igs…
Joined February 2018
13 Photos and videos
🏌️🏌️
ThE_uNKNowN@Johnson__MD
11 Mar 2024
This time next year, I would testify!!!! 🙏#Match2025
226
1,211
17,502
535,524
ThE_uNKNowN retweeted
lfunanya.E, MD@ifuu_md
Oct 22
Internal Medicine Board Certified 🍾🎊 Let’s go!!!!! #ABIM
40
57
651
16,709
ThE_uNKNowN retweeted
Who_is_sk_ 🩺@who_is_sk_
Jul 29
Really glad to be done with this phase!😃 Grateful to God and the people that made this possible. Onto the next🥳
152
89
603
33,667
ThE_uNKNowN retweeted
NEJM
@NEJM
May 31
Presented at #ASCO26: Among patients with previously treated metastatic pancreatic ductal adenocarcinoma, the RAS(ON) inhibitor daraxonrasib led to significantly longer overall survival and progression-free survival than chemotherapy. Full phase 3 RASolute 302 trial results: nej.md/4nWaxvM @ASCO
Graph from a study published in the New England Journal of Medicine on daraxonrasib versus chemotherapy for metastatic pancreatic cancer. The x-axis represents months, and the y-axis shows the percentage of patients alive. Two lines indicate survival rates: daraxonrasib (blue) and chemotherapy (gray). The bottom section lists patients at risk over time. Title and journal logo are included.

ALT Graph from a study published in the New England Journal of Medicine on daraxonrasib versus chemotherapy for metastatic pancreatic cancer. The x-axis represents months, and the y-axis shows the percentage of patients alive. Two lines indicate survival rates: daraxonrasib (blue) and chemotherapy (gray). The bottom section lists patients at risk over time. Title and journal logo are included.

52
2,040
5,562
2,632,813
First ASCO. First year of residency. Grateful to have two first-author abstracts accepted, one poster presentation, and five additional abstracts as a co-author at this year’s ASCO Annual Meeting.
10
27
303
13,111
Thankful for the mentorship, collaboration, and opportunities that made this possible. Excited to continue contributing to oncology research and patient care. #ASCO #Oncology #Research #InternalMedicine #HematologyOncology #PGY1
5
722
Excited and honored to receive the Third Best Clinical Vignette Award along with a cash prize at Boston Medical Center Annual Research Day. #AcademicMedicine #InternalMedicine #Hematology #Oncology #MedicalEducation #Research
14
15
145
7,133
more replies
immunotherapy, but he also underwent MR-guided SBRT targeting the IVC tumor thrombus. Follow-up imaging demonstrated significant regression of both the primary liver tumor and the IVC tumor thrombus. This case highlights the impact of multidisciplinary collaboration and
1
2
509
the evolving role of immunotherapy and advanced radiation techniques in managing complex malignancies. I am thankful for the opportunity to present this work and for the mentorship and encouragement that helped bring it to fruition.
1
406
ThE_uNKNowN retweeted
emmydan@Emmy_dann
Mar 14
Sending my best wishes to IMGs who will find out their Match outcomes in two days.
7
59
395
23,104
ThE_uNKNowN retweeted
lfunanya.E, MD@ifuu_md
24 Dec 2025
Nigerian 🇳🇬 weddings >>
32
164
3,138
48,526
ThE_uNKNowN retweeted
Dana-Farber
@DanaFarber
22 Dec 2025
We’re thrilled that both our adult and pediatric stem cell/bone marrow transplant programs earned the highest possible +1 score in the 2025 @CIBMTR Survival Report — exceeding expected 1-year survival nationwide. Thank you to our dedicated team and partners for advancing patient care every day. Learn more: bit.ly/4pHA7EJ
2
13
75
16,206
It’s not #ASH25 without an award show… Presenting the Multiple Myeloma Golden Globules 🏆🩸- voted on by absolutely no one except a budding-lymphoma doc😊 and a qualified myeloma doc🙌🏾 (both running on caffeine and #ASH adrenaline) 😅 #ASHDailyNews ashpublications.org/ashnewsd…
1
11
772
Ayodeji is a superstar hematologist on his way! Proud of you man
ThE_uNKNowN@Johnson__MD
9 Dec 2025
#ASH2025 grateful for the community
1
6
1,002
Yesterday’s Plenary highlighted important new insights into the biology of DLBCL in African American patients. Catch our full coverage — including key data and expert quotes — in today’s #ASHNewsDaily. #ASH25 ashpublications.org/ashnewsd…
2
8
666
It was a great experience working and learning from this dream team! Special shoutout to the excellent ASH Staffs that made everything seamless! #ASH25
Charlotte Brierley@CKBrierley
8 Dec 2025
It’s been a lot of fun acting as @JoselleCookMD's deputy in bringing #ASH25 ASHNewsDaily to life! Great to finally meet the team IRL today 😍 @ZanwarSaurabh @EmperorBlackMD @majorajay @ChrisGrahamMD @supriyaguptaMD @ASH_hematology
1
1
9
946
#ASH2025 grateful for the community
3
21
2,975
Still energized after my first @AmCollegeGastro meeting. A truly enriching learning experience and a great chance to reconnect with peers and mentors in GI. Proud to have received the #ACG2025 Outstanding Poster Presenter Award. Grateful to @OBHBrookdaleIM for the steady support.
1
5
26
1,105
ThE_uNKNowN retweeted
Who_is_sk_ 🩺@who_is_sk_
13 Sep 2025
Just wrapped up a 3 day inspiring conference on transforming healthcare in Nigeria through tech & innovation(UNIMED), Presented my research for the first time & it was an incredible opportunity to engage with brilliant minds driving change in our healthcare system.
24
60
297
8,942
ThE_uNKNowN retweeted
Ajay. I@lumsbaby_
16 Jul 2025
Active!
BIG FISH
@adekunleGOLD
16 Jul 2025
If you graduated with First class, post your transcripts.
19
46
264
17,573
Load more